Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter Fentz Haastrup, Jane Møller Hansen, Jens Søndergaard & Dorte Ejg Jarbøl. (2021) Proton pump inhibitor use among patients at risk of peptic ulcer bleeding: a nationwide register-based study. Scandinavian Journal of Gastroenterology 56:1, pages 6-12.
Read now
Read now
Hiroto Miwa, Tomomi Takeshima, Kosuke Iwasaki & Shinzo Hiroi. (2016) Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data. Journal of Medical Economics 19:11, pages 1049-1055.
Read now
Read now
Articles from other publishers (18)
Gabriela Leite, Gillian M. Barlow, Ava Hosseini, Gonzalo Parodi, Maya L. Pimentel, Jiajing Wang, Alyson Fiorentino, Ali Rezaie, Mark Pimentel & Ruchi Mathur. (2022) Smoking has disruptive effects on the small bowel luminal microbiome. Scientific Reports 12:1.
Crossref
Crossref
Bando TY, di Pace LS, Lapa M & Chehter EZ. (2022) Proton pump inhibitors: Are they safe?. Gastroenterology & Hepatology: Open Access 13:2, pages 34-47.
Crossref
Crossref
Roel P J Willems, Karin van Dijk, Cindy M Dierikx, Jos W R Twisk, Fiona R M van der Klis, Sabine C de Greeff & Christina M J E Vandenbroucke-Grauls. (2022) Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study. Journal of Antimicrobial Chemotherapy 77:1, pages 237-245.
Crossref
Crossref
Óskar Ö. Hálfdánarson, Anton Pottegård, Sigrún H. Lund, Margret H. Ogmundsdottir, Helga M. Ogmundsdottir & Helga Zoega. (2020) Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer. Basic & Clinical Pharmacology & Toxicology 126:6, pages 484-491.
Crossref
Crossref
Radhika Devraj & Maithili Deshpande. (2020) Demographic and health-related predictors of proton pump inhibitor (PPI) use and association with chronic kidney disease (CKD) stage in NHANES population. Research in Social and Administrative Pharmacy 16:6, pages 776-782.
Crossref
Crossref
Takeshi Kanno & Paul Moayyedi. (2019) Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem. Current Gastroenterology Reports 21:12.
Crossref
Crossref
Ala I. Sharara, Luma Basma O. Rustom, Halim Bou Daher, Hussein H. Rimmani, Rani H. Shayto, Mohamad Minhem, Yervant Ichkhanian, Hanaa Aridi, Amr Al-Abbas, Yasser Shaib, Ramzi Alami & Bassem Safadi. (2019) Prevalence of gastroesophageal reflux and risk factors for erosive esophagitis in obese patients considered for bariatric surgery. Digestive and Liver Disease 51:10, pages 1375-1379.
Crossref
Crossref
Christian Labenz. (2019) PPI bei Leberzirrhose: Freund oder Feind?. Gastro-News 6:3, pages 26-26.
Crossref
Crossref
Chao-Hung Chen, Cha-Ze Lee, Yi-Chun Lin, Li-Ting Kao & Herng-Ching Lin. (2019) Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study. The Journal of Clinical Pharmacology 59:3, pages 350-355.
Crossref
Crossref
Ole K. Bonderup, Gunnar L. Nielsen, Michael Dall, Anton Pottegård & Jesper Hallas. (2018) Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case-control study. Alimentary Pharmacology & Therapeutics 48:6, pages 618-625.
Crossref
Crossref
Ovadyah Avraham & Michael Biglow. (2018) Implementation of Proton Pump Inhibitor Deprescription Protocol in Geriatric Residents. Annals of Pharmacotherapy 52:8, pages 747-753.
Crossref
Crossref
Peter Fentz Haastrup, Wade Thompson, Jens Søndergaard & Dorte Ejg Jarbøl. (2018) Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic & Clinical Pharmacology & Toxicology 123:2, pages 114-121.
Crossref
Crossref
T. S. G. Sehested, T. A. Gerds, E. L. Fosbøl, P. W. Hansen, M. G. Charlot, N. Carlson, M. A. Hlatky, C. Torp-Pedersen & G. H. Gislason. (2018) Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction. Journal of Internal Medicine 283:3, pages 268-281.
Crossref
Crossref
M. Søgaard, U. Heide-Jørgensen, J.P. Vandenbroucke, H.C. Schønheyder & C.M.J.E. Vandenbroucke-Grauls. (2017) Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study. Clinical Microbiology and Infection 23:12, pages 952-960.
Crossref
Crossref
Cristina Llorente, Peter Jepsen, Tatsuo Inamine, Lirui Wang, Sena Bluemel, Hui J. Wang, Rohit Loomba, Jasmohan S. Bajaj, Mitchell L. Schubert, Masoumeh Sikaroodi, Patrick M. Gillevet, Jun Xu, Tatiana Kisseleva, Samuel B. Ho, Jessica DePew, Xin Du, Henrik T. Sørensen, Hendrik Vilstrup, Karen E. Nelson, David A. Brenner, Derrick E. Fouts & Bernd Schnabl. (2017) Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nature Communications 8:1.
Crossref
Crossref
K. Hughes, K.A. Lalikian, J. Schwartz & R.B. Turner. (2017) Are proton pump inhibitors associated with an increased risk of Clostridium difficile infection after considering confounding variables?. Journal of Hospital Infection 95:4, pages 445-446.
Crossref
Crossref
Malcolm D. Kearns, Ben Boursi & Yu-Xiao Yang. (2017) Proton pump inhibitors on pancreatic cancer risk and survival. Cancer Epidemiology 46, pages 80-84.
Crossref
Crossref
Nicole A. Huijgen, Maria A.J. de Ridder, Katia M. Verhamme, Gert R. Dohle, Ann M. Vanrolleghem, Miriam C.J.M. Sturkenboom, Joop S.E. Laven & Régine P.M. Steegers-Theunissen. (2016) Are proton-pump inhibitors harmful for the semen quality of men in couples who are planning pregnancy?. Fertility and Sterility 106:7, pages 1666-1672.e2.
Crossref
Crossref